12/15-Lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo. 2004

Kelly B Reilly, and Suseela Srinivasan, and Melissa E Hatley, and Mary Kim Patricia, and Joanne Lannigan, and David T Bolick, and George Vandenhoff, and Hong Pei, and Rama Natarajan, and Jerry L Nadler, and Catherine C Hedrick
Department of Diabetes, Beckman Research Institute, City of Hope National Medical Center, Duarte, California 91010, USA.

We have shown that the 12/15-lipoxygenase (12/15-LO) product 12S-hydroxyeicosatetraenoic acid increases monocyte adhesion to human endothelial cells (EC) in vitro. Recent studies have implicated 12/15-LO in mediating atherosclerosis in mice. We generated transgenic mice on a C57BL/6J (B6) background that modestly overexpressed the murine 12/15-LO gene (designated LOTG). LOTG mice had 2.5-fold elevations in levels of 12S-hydroxyeicosatetraenoic acid and a 2-fold increase in expression of 12/15-LO protein in vivo. These mice developed spontaneous aortic fatty streak lesions on a chow diet. Thus, we examined effects of 12/15-LO expression on early events leading to atherosclerosis in these mice. We found that, under basal unstimulated conditions, LOTG EC bound more monocytes than B6 control EC (18 +/- 2 versus 7 +/- 1 monocytes/field, respectively; p < 0.0001). Inhibition of 12/15-LO activity in LOTG EC using a 12/15-LO ribozyme completely blocked monocyte adhesion in LOTG mice. Thus, 12/15-LO activity is required for monocyte/EC adhesion in the vessel wall. Expression of ICAM-1 in aortic endothelia of LOTG mice was increased severalfold. VCAM-1 expression was not changed. In a series of blocking studies, antibodies to alpha(4) and beta(2) integrins in WEHI monocytes blocked monocyte adhesion to both LOTG and B6 control EC. Inhibition of ICAM-1, VCAM-1, and connecting segment-1 fibronectin in EC significantly reduced adhesion of WEHI monocytes to LOTG EC. In summary, these data indicate that EC from LOTG mice are "pre-activated" to bind monocytes. Monocyte adhesion in LOTG mice is mediated through beta(2) integrin and ICAM-1 interactions as well as through VLA-4 and connecting segment-1 fibronectin/VCAM-1 interactions. Thus, 12/15-LO mediates monocyte/EC interactions in the vessel wall in atherogenesis at least in part through molecular regulation of expression of endothelial adhesion molecules.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008084 Lipoxygenase An enzyme of the oxidoreductase class primarily found in PLANTS. It catalyzes reactions between linoleate and other fatty acids and oxygen to form hydroperoxy-fatty acid derivatives. Lipoxidase,Linoleate-Oxygen Oxidoreductase,Lipoxygenase-1,Lipoxygenase-2,Linoleate Oxygen Oxidoreductase,Lipoxygenase 1,Lipoxygenase 2,Oxidoreductase, Linoleate-Oxygen
D008297 Male Males
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses

Related Publications

Kelly B Reilly, and Suseela Srinivasan, and Melissa E Hatley, and Mary Kim Patricia, and Joanne Lannigan, and David T Bolick, and George Vandenhoff, and Hong Pei, and Rama Natarajan, and Jerry L Nadler, and Catherine C Hedrick
July 2025, Molecular medicine (Cambridge, Mass.),
Kelly B Reilly, and Suseela Srinivasan, and Melissa E Hatley, and Mary Kim Patricia, and Joanne Lannigan, and David T Bolick, and George Vandenhoff, and Hong Pei, and Rama Natarajan, and Jerry L Nadler, and Catherine C Hedrick
May 2013, The Journal of biological chemistry,
Kelly B Reilly, and Suseela Srinivasan, and Melissa E Hatley, and Mary Kim Patricia, and Joanne Lannigan, and David T Bolick, and George Vandenhoff, and Hong Pei, and Rama Natarajan, and Jerry L Nadler, and Catherine C Hedrick
November 2008, Journal of immunology (Baltimore, Md. : 1950),
Kelly B Reilly, and Suseela Srinivasan, and Melissa E Hatley, and Mary Kim Patricia, and Joanne Lannigan, and David T Bolick, and George Vandenhoff, and Hong Pei, and Rama Natarajan, and Jerry L Nadler, and Catherine C Hedrick
July 2017, Lipids in health and disease,
Kelly B Reilly, and Suseela Srinivasan, and Melissa E Hatley, and Mary Kim Patricia, and Joanne Lannigan, and David T Bolick, and George Vandenhoff, and Hong Pei, and Rama Natarajan, and Jerry L Nadler, and Catherine C Hedrick
August 2008, Trends in cardiovascular medicine,
Kelly B Reilly, and Suseela Srinivasan, and Melissa E Hatley, and Mary Kim Patricia, and Joanne Lannigan, and David T Bolick, and George Vandenhoff, and Hong Pei, and Rama Natarajan, and Jerry L Nadler, and Catherine C Hedrick
June 2006, Arteriosclerosis, thrombosis, and vascular biology,
Kelly B Reilly, and Suseela Srinivasan, and Melissa E Hatley, and Mary Kim Patricia, and Joanne Lannigan, and David T Bolick, and George Vandenhoff, and Hong Pei, and Rama Natarajan, and Jerry L Nadler, and Catherine C Hedrick
January 1992, Proceedings of the National Academy of Sciences of the United States of America,
Kelly B Reilly, and Suseela Srinivasan, and Melissa E Hatley, and Mary Kim Patricia, and Joanne Lannigan, and David T Bolick, and George Vandenhoff, and Hong Pei, and Rama Natarajan, and Jerry L Nadler, and Catherine C Hedrick
November 2010, Journal of immunology (Baltimore, Md. : 1950),
Kelly B Reilly, and Suseela Srinivasan, and Melissa E Hatley, and Mary Kim Patricia, and Joanne Lannigan, and David T Bolick, and George Vandenhoff, and Hong Pei, and Rama Natarajan, and Jerry L Nadler, and Catherine C Hedrick
February 2007, Current opinion in lipidology,
Kelly B Reilly, and Suseela Srinivasan, and Melissa E Hatley, and Mary Kim Patricia, and Joanne Lannigan, and David T Bolick, and George Vandenhoff, and Hong Pei, and Rama Natarajan, and Jerry L Nadler, and Catherine C Hedrick
October 1994, Current opinion in lipidology,
Copied contents to your clipboard!